Manufacturer
European Egyptian for Pharmaceutical Industries Co.(EGYPT)
Registraction Number
MAL19056036ACZ
Content:
Each film-coated tablet contains:
Daclatasvir Dihydrochloride: Equivalent to 60 mg Daclatasvir
Indications:
Chronic Hepatitis C Virus (HCV) Infection: Used in combination with other medicinal products for the treatment of chronic hepatitis C in adults.
Instructions:
Dosage: The recommended dose is 60 mg once daily, taken orally with or without meals. Daclavir must be administered in combination with other medicinal products.
Administration: Swallow the tablet whole with water. Follow your doctor's instructions regarding the timing and duration of the medication.
Malaysia
